14170 Semaglutide for Sale
Compare supplier listings for Semaglutide (CAS 2924330-56-1) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Semaglutide 5mg 10mg 15mg High Purity Lyophilized Powder with Custom Packaging
-
Price:
$53-58/G FOB
-
CAS No.:
910463-68-2
-
Grade:
Cosmetics Grade
-
Content:
99%
-
Packaging:
10mg/vial
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
Semaglutide |GLP-1 Peptides |China &U S Warehouse | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder
-
Price:
$95-100/G FOB
-
CAS No.:
910463-68-2
-
Grade:
Cosmetics Grade
-
Content:
99%
-
Packaging:
20mg/vial
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
SM 99% White powder High Quality semaglutide weight loss
-
Price:
$30/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5/10/15/20/30mg/vial,10vial/box
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
Semaglutide CAS 910463-68-2 5mg 10mg 15mg Per Vial Weight Loss Peptide Lyophilized Powder
-
Price:
Price on request
-
CAS No.:
910463-68-2
-
Grade:
Cosmetic Grade
-
Content:
99%
-
Packaging:
2mg*10vials 5mg/vial,10mg/vial,15mg/vial
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
Semaglutide |GLP-1 Peptides |China &U S Warehouse | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder
-
Price:
Price on request
-
CAS No.:
910463-68-2
-
Grade:
Cosmetics Grade
-
Content:
99%
-
Packaging:
20mg/vial
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
Products You May Be Interested in
High Concentration Semaglutide Powder Long Term Stable Cooperation Supply
-
Price:
Price on request
-
CAS No.:
910463-68-2
-
Grade:
Cosmetic Grade
-
Content:
99%
-
Packaging:
2mg*10vials 5mg/vial,10mg/vial,15mg/vial
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
Advanced Semaglutide Research Peptide with High Purity Standards CAS 910463-68-2
-
Price:
Price on request
-
CAS No.:
910463-68-2
-
Grade:
Cosmetics Grade
-
Content:
99%
-
Packaging:
30mg/vial
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
Research Use Semaglutide Raw Peptide with Reliable Purity CAS 910463-68-2
-
Price:
Price on request
-
CAS No.:
910463-68-2
-
Grade:
Cosmetics Grade
-
Content:
99%
-
Packaging:
10mg/vial
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
Factory Supply Semaglutide Lyophilized Powder for Scientific Research CAS 910463-68-2
-
Price:
Price on request
-
CAS No.:
910463-68-2
-
Grade:
Cosmetics Grade
-
Content:
99%
-
Packaging:
5mg/vial
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
Professional Semaglutide Peptide Manufacturer and Bulk Supplier Worldwide
-
Price:
Price on request
-
CAS No.:
910463-68-2
-
Grade:
Cosmetics Grade
-
Content:
99%
-
Packaging:
15mg/vial
Samaglutide,Tirzepatide,Retatrutide,Ghk-cu
- Buying Semaglutide on www.echemi.com where you will find large variety of good choices. ECHEMI emphasizes on verifying suppliers of Semaglutide who have registered on the platform to ensure the accuracy and reliability of suppliers. Safe transaction of chemical will be made based on true information. Buy Semaglutide with 70000+ customers on ECHEMI and make orders now.
- We guarantee the quality of Semaglutide 2924330-56-1 on ECHEMI. Partners on ECHEMI are all selected in certification, qualification or scale. We help buyers to get Semaglutide with various requirement and regulations in global countries and regions. Further services on the whole supply chain can be provided with ECHEMI.
- We are providing better products and services of Semaglutide with fair price and reasonable deal. Member registered on ECHEMI will enjoy services of Semaglutide for example market price and insights and trade data. Efficient order options is the key for supply chain services we offer for you. Buyers are getting help to grow their business internationally on buying Semaglutide.
- •After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
- •The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
- •Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
- •Torrent Pharma Targets First Wave Semaglutide Launch Revenue Up 11 Percent as Patent Ends
- •New Trial Shows 62 Percent MASH Reversal with Semaglutide as $32 Billion Market Heats Up